GPRC6A regulates prostate cancer progression

Prostate

Volumn 72, Issue 4, 2012, Pages 399-409

  Pi, Min ^a   Quarles, L Darryl ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

calcium; cell proliferation; GPCR; GPRC6A; metastases; osteocalcin; prostate cancer; siRNA

Indexed keywords

ARGININE; CALCIUM; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCALCIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN GPRC6A; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPANESE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOCARCINOMA; ANIMALS; ARGININE; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTAXIS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MALE; MICE; MICE, KNOCKOUT; OSTEOCALCIN; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 82255184385     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21442     Document Type: Article

References (46)

1. Sadar MD, Hussain M, Bruchovsky N,. Prostate cancer: Molecular biology of early progression to androgen independence. Endocr Relat Cancer 1999; 6: 487-502. (Pubitemid 30048459)
2. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 2008; 105: 8369-8374. (Pubitemid 351904762)
3. Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjonneland A, et al. Animal foods, protein, calcium and prostate cancer risk: The European prospective investigation into cancer and nutrition. Br J Cancer 2008; 98: 1574-1581. (Pubitemid 351652328)
4. Giovannucci E, Liu Y, Willett WC,. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev 2006; 15: 2467-2472. (Pubitemid 46048306)
5. Butler LM, Wong AS, Koh WP, Wang R, Yuan JM, Yu MC,. Calcium intake increases risk of prostate cancer among Singapore Chinese. Cancer Res. 2010; 70: 4941-4948.
6. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, et al. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2007; 16: 2623-2630. (Pubitemid 351196317)
7. Wu HC, Lin CC, Chen WC, Chen HY, Tsai FJ,. Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy. Eur Urol 2003; 43: 197-200.
8. Huang WC, Xie Z, Konaka H, Sodek J, Zhau HE, Chung LW,. Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: Role of cAMP-dependent protein kinase A signaling pathway. Cancer Res 2005; 65: 2303-2313. (Pubitemid 40490140)
9. Pratap J, Lian JB, Stein GS,. Metastatic bone disease: Role of transcription factors and future targets. Bone 2011; 48: 30-36.
10. Goldenberg SL, Bruchovsky N, Rennie PS, Coppin CM,. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma. J Urol 1988; 140: 1460-1465. (Pubitemid 19003200)
11. Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, et al. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 2006; 5: 1342-1351. (Pubitemid 43881328)
12. Scher HI, Sawyers CL,. Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 2005; 23: 8253-8261. (Pubitemid 46211563)
13. Wellendorph P, Brauner-Osborne H,. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene 2004; 335: 37-46. (Pubitemid 38759751)
14. Kuang D, Yao Y, Lam J, Tsushima RG, Hampson DR,. Cloning and characterization of a family C orphan G-protein coupled receptor. J Neurochem 2005; 93: 383-391. (Pubitemid 40547495)
15. Sirotnak FM, She Y, Khokhar NZ, Hayes P, Gerald W, Scher HI,. Microarray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular events. Mol Carcinog 2004; 41: 150-163. (Pubitemid 39435112)
16. Wellendorph P, Hansen KB, Balsgaard A, Greenwood JR, Egebjerg J, Brauner-Osborne H,. Deorphanization of GPRC6A: A promiscuous L-alpha-amino acid receptor with preference for basic amino acids. Mol Pharmacol 2005; 67: 589-597. (Pubitemid 40365305)
17. Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 2005; 280: 40201-40209. (Pubitemid 41779157)
18. Pi M, Chen L, Huang MZ, Zhu W, Ringhofer B, Luo J, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One 2008; 3: e3858.
19. Pi M, Parrill AL, Quarles LD,. GPRC6A mediates the non-genomic effects of steroids. J Biol Chem 2010; 285: 39953-39964.
20. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, Kawaguchi T, et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 2010; 42: 751-754.
21. Sutters M, Yamaguchi T, Maser RL, Magenheimer BS, St John PL, Abrahamson DR, et al. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1cells. Kidney Int 2001; 60: 484-494. (Pubitemid 32678892)
22. Mines MA, Goodwin JS, Limbird LE, Cui FF, Fan GH,. Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK activation. J Biol Chem 2009; 284: 5742-5752.
23. National Research Council. Guide for the care and use of laboratory animals, DHHS Publication NIH 86-23. Rockville, MD: Institute on Laboratory Animal Resources; 1985.
24. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005; 8: 393-406. (Pubitemid 41579834)
25. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007; 67: 4010-4015. (Pubitemid 46815044)
26. Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, et al. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 2006; 66: 6118-6128.
27. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92: 3439-3443.
28. Li S, Huang S, Peng SB,. Overexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progression. Int J Oncol 2005; 27: 1329-1339.
29. Whitehead IP, Zohn IE, Der CJ,. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 2001; 20: 1547-1555. (Pubitemid 32336842)
30. Tamler R, Mechanick JI,. Dietary supplements and nutraceuticals in the management of andrologic disorders. Endocrinol Metab Clin North Am 2007; 36: 533-552. (Pubitemid 46817886)
31. Sin WC, Zhang Y, Zhong W, Adhikarakunnathu S, Powers S, Hoey T, et al. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene 2004; 23: 6299-6303. (Pubitemid 39215300)
32. Gannon PO, Godin-Ethier J, Hassler M, Delvoye N, Aversa M, Poisson AO, et al. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer. PLoS One 2010; 5: e12107.
33. Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 2010; 126: 2762-2772.
34. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM,. Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 2001; 281: E1267-E1274. (Pubitemid 34001203)
35. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-826. (Pubitemid 32801464)
36. Liao J, Schneider A, Datta NS, McCauley LK,. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res 2006; 66: 9065-9073. (Pubitemid 44521125)
37. Guo C, Luttrell LM, Price DT,. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines. J Urol 2000; 163: 1027-1032. (Pubitemid 30091682)
38. Price DT, Della Rocca G, Guo C, Ballo MS, Schwinn DA, Luttrell LM,. Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 1999; 162: 1537-1542. (Pubitemid 29428632)
39. Weber MJ, Gioeli D,. Ras signaling in prostate cancer progression. J Cell Biochem 2004; 91: 13-25.
40. Barki-Harrington L, Daaka Y,. Bradykinin induced mitogenesis of androgen independent prostate cancer cells. J Urol 2001; 165: 2121-2125.
41. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK, Shah GV,. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 1997; 30: 160-166. (Pubitemid 27149274)
42. Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, et al. Identification of novel androgen receptor target genes in prostate cancer. Mol Cancer 2007; 6: 39.
43. Yuen HF, Kwok WK, Chan KK, Chua CW, Chan YP, Chu YY, et al. TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenesis 2008; 29: 1509-1518.
44. Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Foller M, Gravanis A, et al. Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Mol Cancer 2008; 7: 88.
45. Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, et al. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Cancer Res 2001; 61: 6012-6019. (Pubitemid 32762530)
46. Bichler KH, Petri E, Hub A, Kleinknecht S, Heidenreich A,. Investigations on bone metabolism of urological tumors forming metastases. Urol Int 1996; 56: 61-68. (Pubitemid 26057269)